Intellia Therapeutics Inc buy Chardan Capital
Start price
18.11.24
/
50%
€13.46
Target price
18.11.25
€86.10
Performance (%)
-46.48%
End price
19.11.25
€7.20
Summary
This prediction ended on 19.11.25 with a price of €7.20. Massive losses of -46.48% were the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 5.993% | 5.993% | 12.432% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target raised by analysts at Chardan Capital from $88.00 to $91.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
3.35%
10:55
10:55
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-18.64%
10:55
10:55
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
31.78%
10:55
10:55
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24